Letrozole (1mg/capsule), 60 Capsules

Letrozole is a third-generation non-steroidal aromatase inhibitor that selectively targets CYP19A1 (aromatase), a cytochrome P450 enzyme responsible for catalyzing key steps in estrogen biosynthesis pathways. By inhibiting aromatase activity, letrozole serves as a valuable research tool for investigating enzyme kinetics, substrate-enzyme interactions, steroidogenic pathway regulation, and feedback mechanisms associated with hormone biosynthesis networks. Experimental studies have examined its effects on CYP19A1-mediated catalytic processes, transcriptional regulation of steroidogenic pathways, and interactions within endocrine signaling systems. Research applications include aromatase enzyme pharmacology, estrogen biosynthesis pathway investigation, steroidogenic enzyme research, and comparative studies of aromatase inhibitor pharmacology.